-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 4, German Chancellor Scholz began his first visit to China since taking office, and at a joint press conference in China, Scholz said that foreign residents in China will be able to receive the new crown vaccine
developed by BioNtech.
"Of course, this is only the first step
.
" Scholz said he hopes the group approved for the vaccine can continue to expand until it is fully free of
charge.
He also said he had talked to the Chinese side about the prospect
of the vaccine being fully approved in China.
The mRNA vaccine is the mRNA new crown vaccine Forbidden, jointly developed by Fosun Pharma and BioNTech of Germany, and after the news was announced, the share price of BioNtech in the US stock market rose all the way
.
.
On March 16, 2020, BioNTech and Fosun Pharma announced that they have reached a strategic cooperation agreement to jointly develop and commercialize vaccine products
against the new coronavirus in Greater China based on BioNTech's proprietary mRNA technology platform.
In the same year, Pfizer also acquired market interests
outside the regions (Germany, Turkey) for which BioNtech was solely responsible.
At the end of 2020, Pfizer/BioNTech's BNT162b2 vaccine became the first COVID-19 vaccine
to receive emergency use authorization in the United States.
In 2021, the regions responsible for Pfizer and BioNTech achieved a total of 40.
1 billion US dollars in sales, and Pfizer achieved 94% revenue growth against the sky, and BioNTech became famous and successfully entered the list of "2021 Global Top 20 Biopharmaceutical Companies
".
1 billion94%
In 2021, Fosun Pharma's sales of Forbidden are also considerable, with 22 million doses vaccinated in Hong Kong, Macao and Taiwan, and it is estimated that the actual sales should be about
2 billion yuan.
Previously, Fosun and Pfizer carried out clinical trials in China and the United States in 2020, but it is reported that in the second half of 2020, at the peak of the epidemic outbreak in the United States, there were more patients, so the clinical progress was faster, and the emergency use right was obtained at the end of the year; At that time, there were fewer Chinese patients, clinical progress was more difficult, and at the same time, considering safety issues, the NMPA was more cautious
about the approval of mRNA vaccines.
The German Chancellor's speech indicates that the progress of Forbidden approval in China has taken another big step, and if it is successfully approved, it will also bring new hope
for the mRNA vaccines and mRNA technologies currently under research in China.
On the issue of supply, it is reported that Fosun and BionTech have also started preparations in advance
.
Reference:
Reference:
